Mistletoe lectin A-chain unfolds during the intracellular transport  by Agapov, Igor I et al.
Mistletoe lectin A-chain unfolds during the intracellular transport
Igor I. Agapova, Alexander G. Tonevitskyb;*, Natalya V. Maluchenkoc,
Mikhail M. Moisenovichc, Yuliya S. Bulaha, Mikhail P. Kirpichnikovd
aState Research Institute of Genetics and Selection of Industrial Microorganisms, 1st Dorozhnyi pr. 1, 113545 Moscow, Russia
bInstitute of Transplantology and Arti¢cial Organs, Shchukinskaya st. 1, 123182 Moscow, Russia
cMoscow State University, Faculty of Biology, Vorobjovi Gori, 119899 Moscow, Russia
dShemyakin p Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya 16/10,
117871 GSP7 Moscow, Russia
Received 1 November 1999; received in revised form 19 November 1999
Edited by Vladimir Skulachev
Abstract Protein conformation during intracellular routing and
translocation of the ribosome-inactivating proteins was investi-
gated on hybridomas producing monoclonal antibodies (monAbs)
against mistletoe lectin (ML). Decrease in the toxin activity
towards these hybridomas is accounted for by the intracellular
interaction of monAbs and the toxin resulting in the interruption
of enzymatic subunit translocation into the cytosol. Obtained
monAbs interacted with denatured ML A-chain (MLA) and a
panel of MLA synthetic octapeptides linked to the surface of
polyethylene pins. Enzyme-linked immunosorbent assay (ELI-
SA) shows that monAbs recognize five epitopes in denatured
MLA. Treatment of MLA by 3 M of guanidine hydrochloride
leads to appearance of the epitopes. Hybridoma TA7 has been
shown to be insensitive to cytotoxic action of ML. TA7 monAb
as we have shown recognizes epitope 101^105, FTGTT, and
inhibits the liposome aggregation induced by MLA. A study of
the cytotoxicity of ML and ricin for the hybridomas revealed
that the unfolding of A-chain is probably required for
intracellular transport and cytotoxic activity of ML.
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1. Introduction
Mistletoe lectin (ML) is a plant toxin isolated from Viscum
album leaves. It belongs to the family of ribosome-inactivating
proteins type II (RIP II) containing two subunits [1]. The A-
chain (MLA) inhibits protein synthesis by enzymatic depuri-
nation of an adenosine residue in a highly conserved loop of
the 28S ribosomal RNA. The B-chain, a lectin, binds to gal-
actose-containing receptors on the cell surface. ML enters the
cell by receptor-mediated endocytosis. Toxin is transported in
vesicles through the endosomal cell compartments and the
Golgi complex and possibly reaches the endoplasmic reticu-
lum (ER) [2]. The mechanism of RIP II transmembrane trans-
location in ER is still unclear. A hypothesis has been ad-
vanced that the toxins utilize the ER translocation
apparatus, which normally exports misfolded proteins from
ER cisterns 1 [3]. Perhaps, toxins mimic such proteins via
speci¢c conformational changes. We previously showed that
the disul¢de bond between ML subunits is reduced and that
the chains dissociate in ER before the MLA is translocated
into the cytosol [4], the intramolecular hydrophobic domain
of MLA being exposed upon dissociation. In the cytosol, mis-
folded proteins are modi¢ed with ubiquitin and hydrolyzed in
proteasomes. MLA can avoid the degradation because of the
absence of Lys residues which are targets for ubiquitination.
MLA can closely interact with phospholipid bilayer because
MLA has been shown to induce aggregation and fusion of
liposomes in vitro [5,6]. Conformational changes of toxins
during their intracellular tra⁄cking remain unclear. Here,
we focused on MLA unfolding before translocation of the
subunit into the cytosol. Hybridomas producing monoclonal
antibodies (monAbs) against denatured ML were used as a
model. The toxin resistance of hybridomas was earlier shown
to be owing to the interaction of the toxin with antibodies
before its translocation into the cytosol [7]. We investigated
in£uence of anti-denatured MLA monAbs on A-chain-in-
duced liposome aggregation. The experiments probe the hy-
pothesis that MLA changes the conformation during intra-
cellular tra⁄cking before translocation into the cytosol.
2. Materials and methods
2.1. Materials
Cell culture medium RPMI 1640, L-glutamine, kanamycin and fetal
calf serum were from Flow Labs (Woodcock Hill, UK); protein
A-Sepharose from LKB-Pharmacia (Uppsala, Sweden); 96-well mi-
crotiter plates from Nunclon (Roskilde, Denmark); streptavidin la-
beled with peroxidase and polyclonal rabbit anti-mouse immunoglo-
bulins from Imtek (Moscow, Russia); all other reagents were obtained
from Sigma (St. Louis, MO, USA).
2.2. Protein puri¢cation and hybridoma production
ML and its subunits were isolated as previously described [5]. The
chimerical toxin consisting of MLA and B-subunit of ricin was pre-
pared as previously described [8]. To produce the hybridomas to
MLA, spleen cells from Balb/c mice immunized with MLA in com-
plete Freund’s adjuvant were hybridized with sp2/0 murine myeloma
cells. The hybridomas were tested by enzyme-linked immunosorbent
assay (ELISA) with biotinylated ML and MLA. MonAbs from ascitic
£uid were puri¢ed by a⁄nity chromatography on protein A-Sephar-
ose. Biotinylation was performed with biotinamidocaproate N-hy-
droxysuccinimide ester as recommended by ‘Sigma’. Protein purity
was estimated with sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (10%).
2.3. Binding and cytotoxic assays
The interaction of monAbs with ML and subunits was analyzed in
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ELISA; the data were read with a spectrophotometer ‘Multiscan’
(LabSystems, Finland). Ricin and ML cytotoxicity was estimated by
cell survival in the (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide test as earlier described [5].
2.4. Epitope prediction and peptide synthesis
Epitopes were predicted on the basis of the data on ML tertiary
structure [9], using the DSSP program to estimate the exposition of
amino acid residues [10]. Data on the temperature B-factor, the ML
secondary structure and the amino acid sequence variation in homol-
ogous proteins were also analyzed. The highest immunogenicity was
assumed for the MLA regions that contained residues with more than
70% surface area exposed, certain secondary structure elements
(mostly L-strands), and had maximum mobility and B-factor. We
synthesized 65 octapeptides overlapping by seven residues and togeth-
er covering MLA regions 1^13, 31^52, 72^108, 112^127, 196^206,
210^229 and 248^255. Peptides were synthesized and attached to
polyethylene pins with di-L-alanine linkers (Chiron Technologies,
Australia) by the active esters coupling procedure using 9-
£uorenylmethyloxycarbonyl-amino acid-penta£uorophenyl esters
(Cambridge Research Biochemicals, UK) in the presence of an equi-
molar amount of 1-hydroxybenzotriazole (Merk, Germany) as de-
scribed earlier [11]. The procedure was drawn up with the PEP-
MAKER program (Chiron Technologies). Synthesis was manually
performed in 96-well plates (Costar, USA). The N-terminal K-amino
groups were acetylated with acetic anhydride, and components pro-
tecting side functional groups of the amino acid residues were re-
moved with the mixture of tri£uoroacetic acid, 1,2-ethanidithiol and
anisole (38:1:1).
2.5. Protein unfolding with guanidine hydrochloride (GndHCl)
GndHCl in di¡erent concentrations was added to 0.01 mg/ml of
biotinylated MLA and incubated for 60 min at room temperature.
For ELISA, the protein probes were dissolved before experiment by
100 times in phosphate-bu¡ered saline.
2.6. Liposome preparation and aggregation
Small unilamellar liposomes were produced by drying 1 ml diphy-
tanoylphosphatidylcholine solution in chloroform (1 mM), on a rotor
evaporator. Dried lipid ¢lm was hydrated by bu¡er containing 5 mM
TES, 140 mM NaCl, 1 mM EDTA, at pH 7.5. The mixture was
treated for 5 min with ultrasound in a nitrogen atmosphere (50 W,
22^28 kHz) at +4‡C. Liposome aggregation was monitored from op-
tical density measurements at a wavelength of 350 nm after 30 min
incubation with proteins at 37‡C using an UV-VIS spectrophotometer
‘Ultrospec’ (LKB-Pharmacia, Sweden). The concentration of lipids in
liposome solution was 0.1 mM, MLA 1 WM, monAbs 3 WM.
3. Results and discussion
Mice immunization with MLA combined with the complete
Freund’s adjuvant yielded monAb preferentially recognizing
the denatured protein. The adjuvant could change the protein
conformation so that the inner hydrophobic fragments be-
came exposed [12]. Hybridomas TA7, TA71, TA72, TA73,
TA74, TA75, TA76 and TA77 producing monAb with the
highest a⁄nity for MLA were selected and cloned. Cytotoxic
activity of ML on hybridoma cells has been determined and
hybridomas were divided into three groups with ML resis-
tance: 15 times higher (TA7) (Fig. 1), comparable (TA72,
TA73 and Ta74) or 3^5 times lower (TA71, TA75, TA76
and TA77) than of sp2/0 cells. The toxin concentration caus-
ing death of 50% of cells (IC50) of ricin on hybridomas was
used to correct the above data for antibody-independent toxin
resistance. For instance, the ricin resistance of TA7 hybrid-
oma was 1.5 times higher than that of sp2/0. With such cor-
rection, TA7 cells proved to have a 10 times higher ML re-
sistance as compared with sp2/0.
The sensitivity of hybridoma cells producing monAbs to
ML depends on the intracellular interaction of monAb with
toxin molecules. Additionally, monAbs in the hybridoma cul-
ture media might prevent ML binding to the cells. We ex-
cluded this binding by repeated washing of cells with cell
culture media without serum. The maximum number of bind-
ing sites for ML on speci¢c and control hybridoma cells does
not di¡er (data not shown). Papain treatment of the cells to
eliminate external monAb molecules does not change the sen-
sitivity to the toxin [7]. Thus, hybridoma cell resistance is due
to intracellular interaction of toxins with newly synthesized
antibody molecules.Antibody speci¢city was assayed with na-
tive, denatured and adsorbed on plate MLA, ML, ricin and
ricin A-chain (RTA). Ricin and RTA were used as controls,
since ricin and ML are similar in intracellular pathway, mech-
anism of action, amino acid sequence and tertiary structure
[9,13]. All monAbs had comparable a⁄nities for MLA ad-
sorbed on a plate. TA71, TA75 and TA77 monAbs did not
react with denatured ML, as observed with denatured MLA.
These monAbs bound with adsorbed RTA and, less e⁄-
ciently, with native RTA. The cross-interaction of these mon-
Abs with ricin and RTA is explained by its amino acid ho-
mology and structural similarity with ML and MLA.
Interestingly, neither of these monAbs conferred ricin resis-
tance to the corresponding hybridomas. Competitive enzyme
immunoassay allowed division of hybridomas into ¢ve groups
di¡ering in monAb speci¢city: (1) TA72, TA73; (2) TA74; (3)
TA71, TA75, TA77; (4) TA76 and (5) TA7. TA5 monAb
against native MLA [14] was used as a control. MonAbs
from di¡erent groups showed a partial cross-reactivity. Thus
antigen binding with TA72 and TA73 monAbs decreased
binding with TA7 monAb completely and with other monAbs
on about 50^60%. The resistance of TA7 hybridoma to ML is
possibly determined by the speci¢city of monAb produced.
Assuming that the ML epitope(s) recognized by monAbs
play the crucial role in cytotoxicity, we attempted to locate
them. The epitope prediction algorithms allowed us to select
the most immunogenic regions of MLA. In total, they com-
prised 31% of the MLA amino acid sequence. The corre-
sponding octapeptides were synthesized (Fig. 2, at the top).
Peptides numbered 1^6 include residues 1^13; no. 7, 31^38;
nos. 8^12, 41^52; nos. 13^42, 72^108; nos. 43^51, 112^127;
no. 52, 161^168; nos. 53 and 54, 174^182; nos. 55^58, 196^
Fig. 1. IC50 of ML and ricin on hybridoma cells synthesizing mon-
Abs against MLA.
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206; nos. 59^61, 210^219; no. 62, 222^229; nos. 63 and 64,
231^239; and no. 65, 248^255. The serum of MLA-immunized
mice whose spleen cells had been taken for fusion with sp2/0
cells to produce our hybridomas was used as positive control.
Serum polyclonal antibodies interacted with peptides contain-
ing residues 5^12, 45^52, 81^90, 93^103, 116^123 and 211^218
from the MLA sequence (Fig. 2). The most e⁄cient interac-
tion was with region 93^103 also recognized by TA72 and
TA73 monAbs. These monAbs less e⁄ciently bound with
peptides containing residues 81^90. TA7 monAb interacted
with peptides of the neighboring region 98^108 and had a
markedly lower a⁄nity for those of regions 75^83, 87^94
and 196^204 (Fig. 2). TA71, TA75 and TA76 monAbs
showed a low a⁄nity for octapeptides from region 93^103
or 95^103. These results were consistent with the above data
on monAb cross-reactivity. Octapeptides from region 93^103
recognized by TA72 and TA73 monAbs are a loop formed by
a L-strand and partly exposed on the protein surface [9]. The
sequence of the epitope is AETHL, 96^100. Comparison of
the RTA and MLA sequences showed that a similar epitope is
presented in RTA sequence: 102^106, AITHL. The protein
loop 93^108 is highly immunogenic and is involved in various
epitopes. This loop is not hidden by B-subunit in holotoxin
[9]. The region overlaps with the octapeptides binding TA7
monAb (98^108) and weakly binds with TA71, TA76 and
TA75 monAbs. This explains the competitive ELISA data
that the high-a⁄nity binding with TA72 and TA73 monAbs
prevented binding with other monAbs but could not be more
than 35% suppressed by any of them. TA7 epitope is 101^105,
FTGTT, and also partly exposed on the protein surface [9].
This epitope is not present in RTA sequence. GndHCl dena-
tured MLA and unfolded subunit reacted with TA7 monAb
with middle point 4 M of GndHCl (Fig. 3). MonAb MNA5
against native MLA [4] does not bind subunit after GndHCl
treatment.
TA7 monAb suppressed MLA-induced liposome aggrega-
tion (Fig. 4), which is well consistent with the ML resistance
of hybridoma TA7. Hence, TA7 monAb recognizes MLA in
complex with the phospholipid bilayer and suppresses this
interaction. As noted above, the resistance of hybridoma cells
depends on the intracellular interaction of their monAb with
toxin molecules and, therefore, on the monAb speci¢city
[7,14]. MonAb to denatured ML may not recognize its epitope
in the cell for many reasons. Epitopes hidden inside the glob-
ular molecule may not become exposed during the ML trans-
port. If such conformational changes occur, the life time of
the unfolded molecule may be too short for its interaction
with monAb. This may be the case when toxin penetrates
the lipid bilayer or when monAb and toxin molecules are
distant from each other in a intracellular compartment, and
the toxin unfolded for translocation has a chance to escape
binding with monAb. The resistance of TA7 hybridoma to
ML shows that TA7 molecules bind toxin molecules in intra-
cellular compartments. This requires ML to be unfolded dur-
ing its intracellular transport, because TA7 monAb reacts
only with partly denatured MLA. The toxin sensitivity of
the other hybridomas producing monAbs to denatured
MLA suggests that the unfolded MLA molecule exposes
only the epitope for TA7 monAb. This explanation is quite
Fig. 2. Epitope mapping in MLA. The results of peptide scanning with monAbs are schematically represented. Optical density at 405 nm: (E)
0.05^1; and (F) 1^3.
Fig. 3. E¡ect of monAbs on liposome aggregation induced by
MLA.
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in line with the data on suppression of the MLA interaction
with liposomes by TA7 monAb.
The ML resistance of TA7 is far lower than that of hybrid-
omas MNA8 and MNA9 producing monAbs against the na-
tive toxin: compared with control cells, they are 600 times less
sensitive to ML [4]. Possibly, a transition state of the toxin
with the TA7 epitope exposed is a short-lived one.
Thus, our studies have revealed that the MLA molecule is
partly unfolded before the toxin is translocated into the cyto-
sol. Introduction of a single disul¢de bond in RTA (i.e. ¢x-
ation of its conformation) has been shown to reduce dramat-
ically its translocation [15]. The unfolding of the toxin in a cell
compartment may result from its interaction with cell trans-
port proteins or from its direct contact with the membrane.
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